The immune system is clearly an important regulator of tumor development.
The immune system is clearly an important regulator of tumor development. 1 In contrast to the antigen-specific regulation of adaptive immunity, natural killer (NK) cell-mediated responses are controlled by receptors that convey activating or inhibitory signals. Early studies of NK cell inhibition demonstrated that the absence of MHC Class I molecules on the surface of cancer cells resulted in their clearance, leading to the "missing self " hypothesis. 2 Molecular data in support of this model was provided with the identification of MHC Class I recognition by the inhibitory receptor Ly49A. The "missing self " theory proposed that the absence of MHC Class I molecules should render cells more susceptible to NK cell-mediated killing. An extension of this model was the "at least one" proposal, suggesting that-for missing self to be activeeach NK cell must express an inhibitory receptor that recognizes self MHC molecules. 3 However, neither of these models can completely explain NK-cell tolerance, since not all Ly49 molecules have been shown to bind to host MHC molecules and NK cells from MHC Class I-deficient mice do not acquire full effector function. These facts raised some doubt about the fidelity of NK-cell inhibitory receptor interactions with MHC Class Ia molecules.
Members of the non-classical MHC Class Ib family, most significantly Rae/ULBP (NKG2D) and HLA-E/Qa-1b (NKG2ACE), also regulate the functions of NK cells. Given the importance of these non-classical MHC molecules in NK-cell function, it is surprising to note that whether other members of this family actively regulate NK cell biology has not been intensively investigated. H2-M3 is a relatively non-polymorphic MHC Class Ib molecule from the same non-classical region as Qa-1b, and was first identified as a minor histocompatibility antigen. The mRNA encoding H2-M3 can be found in most tissues of all strains of mice at a lower level than that coding for classical MHC Class I molecules. However, in contrast to classical MHC molecules, most cells do not express H2-M3 on their surface, B cells being a notable exception. H2-M3 specifically binds N-formylated peptides that contain hydrophobic residues with an affinity 100-1000 times greater than that for standard peptides. Given that prokaryotes and mitochondria are the only sources of N-formylated peptides, H2-M3 appears to have evolved to present peptides of bacterial (or mitochondrial) origin. 4 Indeed, in the past 20 years attention has been focused on the of role H2-M3 in the biology of a subset of CD8 + T cells. Intriguingly, the first description of H2-M3-deficient mice reported an impaired capacity of lymphocytes from these mice to kill NK cell-sensitive targets. 5 Our recent findings demonstrate that H2-M3 can be recognized by Ly49A, the prototypic NK-cell inhibitory receptor. 6 This existence of non-classical MHC Class Ib molecule-binding receptors specific for allotypic classical Class I indicates that there may be a previously unrecognized crossover between these receptor-ligand families. Potentially, this result provides further support to the "at least one" hypothesis and suggests that ligands for Ly49 (and potentially KIR) may exist outside the classical MHC family. From a functional standpoint, the absence of H2-M3 results in NK-cell hyporesponsiveness (due to the ineffective licensing of the Ly49A + NK-cell subset) and missing-self rejection (H2-M3 acts a self molecule recognized by NK cells) (Fig. 1) . Consequently, H2-M3-deficient mice display increased sensitivity to oncogenesis, tumor progression and metastatic spread, the latter in a Ly49A-dependent fashion. Distinct genetic and phenotypic of whether other Ly49 molecules have non-MHC Class Ia binding partners.
The ability of H2-M3 to present mitochondrial peptides raises the interesting possibility that interactions with Ly49A-expressing lymphocytes may be controlled by mitochondrial integrity. A number of tumor cell lines constitutively express H2-M3. In addition, H2-M3 can be induced by a number of potentially lethal stimuli in B16F10 melanoma cells including ionizing radiation, mitomycin C, 5-fluorouracil, and the histone deacteylase inhibitor LBH. This pattern of induction is distinct from that observed for NKG2D ligands, which are mainly upregulated upon the activation of the DNA damage response. 10 Whether mitochondrial peptides are exposed on the cell surface in the context of H2-M3 following these insults remains to be established. One might imagine that such exposure may regulate peripheral Ly49A
+ lymphocyte subsets in situations of stress or inflammation.
While the ability of classical MHC Class Ia molecules to present tumor antigens to CD8 + T cells is a fundamental premise for most modern cancer immunotherapies, the role of non-classical MHC Class Ib molecules in regulating the immune response to cancer deserves greater attention.
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foreign (microbial) antigens have been described in humans. 8 HLA-F is physiologically expressed by cell types similar to those that express H2-M3, and has been shown to bind inhibitory ILT-2 and ILT-4 receptors. Still, HLA-F lacks an obvious consensus sequence for the binding of N-formylated peptides. HLA-E and HLA-G are the best studied non-classical MHC-like molecules, 9 but a better characterization of the functions of MHC-linked Class Ib loci in humans and mice (H2-Q, H2-T, and H2-M) is required. Similarly, our work should prompt an examination alterations of tumor cells allow for their escape from the control of the immune system, representing a critical step in cancer progression. 7 The ability of inhibitory Ly49A to bind H2-M3, which is constitutively expressed by some malignant cells, suggests that tumors may potentially use this interaction to escape both NK and Ly49A-expressing T cells.
Although there is not a direct human homolog of H2-M3, it is possible that a functional homolog exists. Indeed, T-cell responses to N-formylated peptides derived from self (mitochondrial) and 
